Daily symptom ratings for studying premenstrual dysphoric disorder: A review

Renske C. Bosman*, Sophie E. Jung, Kristina Miloserdov, Robert A. Schoevers, Marije aan het Rot

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

21 Citations (Scopus)
386 Downloads (Pure)

Abstract

Background: To review how daily symptom ratings have been used in research into premenstrual dysphoric disorder (PMDD), and to discuss opportunities for the future.

Methods: PsycINFO and Medline were systematically searched, resulting in the inclusion of 75 studies in which (1) participants met the diagnostic criteria for late luteal phase dysphoric disorder (LLPDD) or PMDD and (2) diaries were used to study LLPDD/PMDD.

Results: To date, diaries have been used to gain insight into the aetiology and phenomenology of PMDD, to examine associated biological factors, and to assess treatment efficacy. We found low consistency among the diaries used, and often only part of the menstrual cycle was analysed instead of the whole menstrual cycle. We also observed that there was substantial variability in diagnostic procedures and criteria.

Limitations: This review excluded diary studies conducted in women with premenstrual syndrome, women seeking help for premenstrual complaints without a clear diagnosis, and women without premenstrual complaints.

Conclusions: Prospective daily ratings of symptoms and related variables provide a valuable and important tool in the study of PMDD. This paper addresses some options for improving the use of diaries and proposes the use of experience sampling and ecological momentary assessment to investigate within-person variability in symptoms in more detail. (C) 2015 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)43-53
Number of pages11
JournalJournal of Affective Disorders
Volume189
DOIs
Publication statusPublished - 1-Jan-2016

Keywords

  • Premenstrual syndrome
  • Menstrual cycle
  • Premenstrual dysphoric disorder
  • Daily ratings
  • Diaries
  • PLACEBO-CONTROLLED TRIAL
  • RANDOMIZED-CONTROLLED-TRIAL
  • PHASE SERTRALINE TREATMENT
  • ECOLOGICAL MOMENTARY ASSESSMENT
  • PAROXETINE CONTROLLED-RELEASE
  • SEROTONIN REUPTAKE INHIBITOR
  • LUTEAL-PHASE
  • DOUBLE-BLIND
  • MENSTRUAL-CYCLE
  • DULOXETINE TREATMENT

Fingerprint

Dive into the research topics of 'Daily symptom ratings for studying premenstrual dysphoric disorder: A review'. Together they form a unique fingerprint.

Cite this